Retreat program
Saturday, January 26
Sunday, January 27
Monday, January 28
Tuesday, January 29
Wednesday, January 30
9:00 – 9:45
9:00 – 9:45
Registration
9:45 – 10:00
9:45 – 10:00
Opening ceremony
10:00 – 10:50
10:00 – 10:50
Role of the Drosophila CPEB protein Orb in the process of oocyte specification
Paul Sсhedl, Princeton University
11:10 – 12:00
11:10 – 12:00
3D genomics
Sergei Razin, Institute of Gene Biology, Russian Academy of Sciences
12:05 – 12:55
12:05 – 12:55
Chromosome-wide fine-tuning of transcription in Drosophila: models — mechanism — mystery
Peter Becker, Ludwig Maximilian University of Munich
14:00 – 14:50
14:00 – 14:50
Aging, and supervisors of cell Identity
Amir Orian, Technion – Israel Institute of Technology
14:55 – 15:45
14:55 – 15:45
Functions of the dynamic SAGA complex in neuroprotection
Ryan Mohan, University of Missouri – Kansas City
16:05 – 16:55
16:05 – 16:55
Error-corrected next generation sequencing to profile clonal hematopoiesis before, during and after leukemia treatment
Todd Druley, Washington University in St. Louis
17:00 – 17:15
17:00 – 17:15
New QIAGEN's paradigm of NGS analysis: from sample to insight
Alexey Anikaev, QIAGEN
18:30 – 21:00
18:30 – 21:00
Networking, venture contest
10:00 – 10:50
10:00 – 10:50
DNA polymerases and origin of mutations
Youri Pavlov, University of Nebraska Medical Center
11:10 – 12:00
11:10 – 12:00
Uncovering the relation between RNA and DNA in genome stability
Francesca Storici, Georgia Institute of Technology
12:05 – 12:55
12:05 – 12:55
Transcription and histone-based chromatin in archaea
Finn Werner, University College London
14:00 – 14:50
14:00 – 14:50
Understanding the pathways of DNA palindrome processing in E. coli. Lessons from a 35-year journey of discovery
David Leach, University of Edinburgh
14:55 – 15:45
14:55 – 15:45
RNA interference and piRNA function
Alexei Aravin, California Institute of Technology
15:50 – 16:05
15:50 – 16:05
Illumina: unlocking the power of genome
Nikolay Egorov, ALBIOGEN
16:25 – 17:15
16:25 – 17:15
Dawn of the biopharmaceutical industry in Russia: personal and professional account
Dmitry Poteryaev, IBC Generium
17:20 – 18:10
17:20 – 18:10
Venture funding in drug development
Ilya Yasny, Pharmstandard Ventures
18:15 – 18:30
18:15 – 18:30
Immunotherapy technologies for cancer treatment
Ekaterina Avilova, GE Healthcare
19:40 – 20:30
19:40 – 20:30
Houdini Prize: the scientific method and paranormal claims
Alexander Panchin, Institute for Information Transmission Problems, Russian Academy of Sciences
10:00 – 10:50
10:00 – 10:50
How the ribosome accurately builds proteins: visualizing translation by cryo-EM
Andrei Korostelev, University of Massachusetts Medical School
11:10 – 12:00
11:10 – 12:00
Structural basis for protein synthesis inhibition by ribosome-targeting antimicrobial peptides
Matthieu Gagnon, University of Texas Medical Branch
12:05 – 12:55
12:05 – 12:55
Translation initiation and human diseases
Ivan Lomakin, Yale University
14:00 – 14:50
14:00 – 14:50
Systems biology of aging
Vadim Gladyshev, Harvard Medical School
14:55 – 15:45
14:55 – 15:45
Translational control under stress: implications for health and disease
Pavel Ivanov, Harvard Medical School
16:05 – 16:55
16:05 – 16:55
Modification of ribosomal RNA
Petr Sergiev, Moscow State University, Skolkovo Institute of Science and Technology
17:00 – 17:50
17:00 – 17:50
Biotechnology in Russia and the world: a market review
Nadezhda Orlova, Abercade Consulting
19:00 – 21:00
19:00 – 21:00
Round table. Superbugs and new antibiotics
Yury Polikanov, Discussion leader, University of Illinois at Chicago
10:00 – 10:50
10:00 – 10:50
Evolutionary outcomes of CRISPR-anti-CRISPR conflict
Blake Wiedenheft, Montana State University
11:10 – 12:00
11:10 – 12:00
Functional prediction for uncharacterized protein families using computational biology methods
Kira Makarova, National Center for Biotechnology Information
12:05 – 12:55
12:05 – 12:55
CRISPR adaptation — the ghost of Lamarck
Konstantin Severinov, Skolkovo Institute of Science and Technology
This work was supported by the Ministry of Science and Higher Education of the Russian Federation, agreement No. 14.606.21.0006, a unique project identifier RFMEFI60617X0006
13:00 – 13:15
13:00 – 13:15
Skoltech programs presentation
Denis Stolyarov, Skolkovo Institute of Science and Technology
14:20 – 15:10
14:20 – 15:10
Generation of transgenic mice with help of the CRISPR/cas9 system. How to detect the genomic rearrangement at the targeted locus
Boris Skryabin, University of Münster
15:15 – 15:30
15:15 – 15:30
Biomek hands-free gene editing
Artem Bogomolov, Beckman Coulter
15:35 – 16:20
15:35 – 16:20
Current challenges in the field of genome editing with targeted genomic nucleases
Dmitriy Madera, BIOCAD
16:20 – 21:00
16:20 – 21:00
Free time
10:00 – 10:50
10:00 – 10:50
Single-cell resolution lineage tracing of cell fate reprogramming
Samantha Morris, Washington University in St. Louis
11:10 – 12:00
11:10 – 12:00
Gene therapy for refractory epilepsy: how far from the clinic?
Dimitri Kullmann, Institute of Neurology, University College London
12:05 – 12:55
12:05 – 12:55
Evolving haematopoietic stem cell gene therapy
Adrian Thrasher, University College London
14:00 – 14:50
14:00 – 14:50
Reverse genetics in biomedical research
Sergei Nedospasov, Institute of Molecular Biology, Russian Academy of Sciences
14:55 – 15:45
14:55 – 15:45
Screening of biodiversity
Alexander Gabibov, Institute of Bioorganic Chemistry, Russian Academy of Sciences
16:05 – 16:55
16:05 – 16:55
Genetic medicines: coming of age
Dmitry Kuzmin, 4BIO Capital
17:00 – 20:00
17:00 – 20:00
Science quiz, Closing ceremony
Made on
Tilda